Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BioSphere Medical Inc.

Division of Merit Medical Systems Inc.
www.biospheremed.com

Latest From BioSphere Medical Inc.

Medtech Start-Ups Innovate In Minimally Invasive Gynecology

Medtech start-ups are taking on the global endometrial ablation and uterine artery embolization markets with next-generation systems designed to raise the standard of care in menorrhagia treatment. Profiles of Channel Medsystems, EmboMedics, and Minerva Surgical.

Medical Device

EmboMedics Inc.

EmboMedics Inc. has developed a bioresorbable embolic bead technology to treat uterine fibroids without causing long-term side effects. Currently in preclinical testing, EmboMedics' technology will initially be used in the treatment of uterine fibroids, although its potential for controlled and predictable drug release could lend itself to a variety of other acute and chronic indications, including liver and prostate cancer, trauma, and obesity.

Medical Device Surgical Procedures

Surefire Medical Inc.

Current embolic therapies for cancer have one major drawback. When they're introduced into a vessel through a catheter, reflux often occurs along the catheter, sending the medication backward into another vessel and into non-targeted tissue. The safety of these could greatly improve with Surefire Medical's new embolic therapy catheter. Surefire's initial therapeutic target is liver cancer.
Medical Device

Start-Up News

Noteworthy news from medtech start-ups. This month we profile Surefire Medical, which is developing a novel embolotherapy catheter for treating liver cancer and Magnetecs, which is developing a real-time, robotic navigational system for radiation frequency ablation of cardiac rhythm disturbances. These company profiles first appeared in Start-Up magazine.
Medical Device
See All

Company Information

  • Industry
  • Biotechnology
  • Medical Devices
    • Biomaterials
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Cardiovascular
  • Gynecological, Urological
  • Alias(es)
  • BioSepra Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Merit Medical Systems Inc.
  • Senior Management
  • Richard J Faleschini, Pres. & CEO
    Martin J Joyce, EVP, CFO
    Willard W Hennemann, PhD, VP, New Product & Bus. Dev.
    Joel B Weinstein, VP, Global Mktg. & Sales
  • Contact Info
  • BioSphere Medical Inc.
    Phone: (781) 681-7900
    1050 Hingham St.
    Rockland, MA 02370
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register